- Laboratory
- Laboratory medicine
- COVID-19 rapid test
- Biowin Pharmaceutical
COVID-19 rapid test EUAfor antigensSARS-COV-2saliva
Add to favorites
Compare this product
Characteristics
- Applications
- COVID-19
- Tested parameter
- for antigens
- Micro-organism
- SARS-COV-2
- Sample type
- nasal, saliva
- Analysis mode
- immunochromatographic
Description
Rapid SARS-CoV-2 Antigen Test Card is an immunochromatography based one step in vitro test. It is designed for the rapid qualitative determination of SARS-CoV-2 virus antigen in anterior nasal swabs from individuals suspected of COVID-19 within the first seven days of symptom onset. Rapid SARS-CoV-2 Antigen Test Card shall not be used as sole basis to diagnose or exclude SARS-CoV-2 infection. Children under 14 years of age should be assisted by an adult.
Catalogs
No catalogs are available for this product.
See all of Biowin Pharmaceutical‘s catalogs
Related Searches
- Assay kit
- Blood assay kit
- Serum assay kit
- Immunoassay assay kit
- Plasma assay kit
- Rapid lateral flow test
- Immunoassay rapid diagnostic test
- Respiratory infection test kit
- Virus rapid diagnostic test
- Whole blood detection kit
- COVID-19 assay kit
- Lateral flow test kit
- Rapid respiratory infection test
- Antigen assay kit
- COVID-19 rapid diagnostic test
- Oral fluid test kit
- Coronavirus detection kit
- Nasal rapid diagnostic test
- Nasal assay kit
- Infection detection kit
*Prices are pre-tax. They exclude delivery charges and customs duties and do not include additional charges for installation or activation options. Prices are indicative only and may vary by country, with changes to the cost of raw materials and exchange rates.